NOVAVAX INC (NVAX) Shareholder Equity
- 2026-06-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.68M; Additional Paid in CapitalUSD $4.56B; Treasury Stock, Common, ValueUSD $112.37M.
- 2026-03-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.68M; Additional Paid in CapitalUSD $4.55B; Treasury Stock, Common, ValueUSD $112.32M.
- 2025-12-31: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.65M; Additional Paid in CapitalUSD $4.54B; Treasury Stock, Common, ValueUSD $103.02M.
- 2025-09-30: Preferred Stock, Value, IssuedUSD $0.00; Common Stock, Value, IssuedUSD $1.65M; Additional Paid in CapitalUSD $4.53B; Treasury Stock, Common, ValueUSD $102.66M.
NOVAVAX INC Shareholder Equity
Filed components and totals, with each concept and unit kept separate. Components can overlap; they are not added together. Missing disclosures remain (m). Original concept pages retain their detailed breakdowns and history.
| Period end | Preferred Stock, Value, Issued USD | Common Stock, Value, Issued USD | Additional Paid in Capital USD | Treasury Stock, Common, Value USD | Accumulated Other Comprehensive Income (Loss), Foreign Currency Translation Adjustment, Net of Tax USD | Accumulated Other Comprehensive Income (Loss), Net of Tax USD | Retained Earnings (Accumulated Deficit) USD | Stockholders' Equity Attributable to Parent USD | Treasury Stock, Common, Shares shares | Adjustments to Additional Paid in Capital, Stock Issued, Issuance Costs USD | APIC, Share-based Payment Arrangement, Increase for Cost Recognition USD | Treasury Stock, Value USD | Adjustments to Additional Paid in Capital, Convertible Debt with Conversion Feature USD | Adjustments to Additional Paid in Capital, Income Tax Benefit from Share-based Compensation USD | Treasury Stock, Shares shares |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 2026-06-30 | $0.00 | $1.68M | $4.56B | $112.37M | (m) | $-7.45M | $-4.63B | $-190.71M | 3.35M | (m) | 3 month · $8.09M 6 month · $15.81M | (m) | (m) | (m) | (m) |
| 2026-03-31 | $0.00 | $1.68M | $4.55B | $112.32M | (m) | $-5.07M | $-4.58B | $-144.76M | 3.34M | (m) | 3 month · $7.72M | (m) | (m) | (m) | (m) |
| 2025-12-31 | $0.00 | $1.65M | $4.54B | $103.02M | $2.00M | $2.01M | $-4.57B | $-127.75M | 2.39M | (m) | 12 month · $36.02M | (m) | (m) | (m) | (m) |
| 2025-09-30 | $0.00 | $1.65M | $4.53B | $102.66M | (m) | $-1.75M | $-4.59B | $-156.67M | 2.35M | (m) | 3 month · $8.55M 9 month · $28.05M | (m) | (m) | (m) | (m) |
| 2025-06-30 | $0.00 | $1.65M | $4.52B | $102.46M | (m) | $-458.00K | $-4.38B | $37.62M | 2.32M | (m) | 3 month · $9.21M 6 month · $19.50M | (m) | (m) | (m) | (m) |
| 2025-03-31 | $0.00 | $1.64M | $4.51B | $101.94M | (m) | $1.61M | $-4.49B | $-75.64M | 2.25M | (m) | 3 month · $10.29M | (m) | (m) | (m) | (m) |
| 2024-12-31 | $0.00 | $1.62M | $4.50B | $95.85M | $-22.60M | $-22.56M | $-5.01B | $-623.84M | 1.52M | 12 month · $3.83M | 12 month · $48.15M | (m) | (m) | (m) | (m) |
| 2024-09-30 | $0.00 | $1.62M | $4.49B | $94.86M | (m) | $3.60M | $-4.93B | $-526.44M | 1.41M | 9 month · $3.83M | 3 month · $12.05M 9 month · $37.70M | (m) | (m) | (m) | (m) |
| 2024-06-30 | $0.00 | $1.61M | $4.48B | $94.44M | (m) | $-10.51M | $-4.81B | $-431.71M | 1.38M | 3 month · $3.83M 6 month · $3.83M | 3 month · $14.10M 6 month · $25.66M | (m) | (m) | (m) | (m) |
| 2024-03-31 | $0.00 | $1.42M | $4.20B | $93.95M | (m) | $-10.82M | $-4.97B | $-867.08M | 1.33M | (m) | 3 month · $11.56M | (m) | (m) | (m) | (m) |
| 2023-12-31 | $0.00 | $1.41M | $4.19B | $92.27M | $2.70M | $2.72M | $-4.82B | $-716.93M | 1.00M | 12 month · $6.17M | 12 month · $85.85M | (m) | (m) | (m) | (m) |
| 2023-09-30 | $0.00 | $1.20M | $4.07B | $91.71M | $-11.90M | $-11.86M | $-4.64B | $-678.35M | 911.27K | 3 month · $3.06M 9 month · $3.92M | 3 month · $21.25M 9 month · $70.19M | (m) | (m) | (m) | (m) |
| 2023-06-30 | $0.00 | $952.00K | $3.86B | $91.42M | $-8.20M | $-8.18M | $-4.51B | $-754.52M | 875.37K | 3 month · $861.00K 6 month · $861.00K | 3 month · $20.29M 6 month · $48.94M | (m) | (m) | (m) | (m) |
| 2023-03-31 | $0.00 | $871.00K | $3.77B | $91.23M | $-3.20M | $-3.17M | $-4.57B | $-895.58M | 848.36K | (m) | 3 month · $28.65M | (m) | (m) | (m) | (m) |
| 2022-12-31 | $0.00 | $868.00K | $3.74B | $90.66M | $-6.40M | $-6.38M | $-4.28B | $-634.08M | 766.63K | 12 month · $7.22M | 12 month · $131.97M | $90.66M | (m) | (m) | 766.63K |
| 2022-09-30 | (m) | $792.00K | $3.64B | (m) | $-23.80M | $-23.79M | $-4.09B | $-565.99M | (m) | 9 month · $2.31M | 3 month · $33.39M 9 month · $104.37M | $89.94M | (m) | (m) | 727.70K |
| 2022-06-30 | (m) | $788.00K | $3.60B | (m) | $-10.90M | $-10.87M | $-3.93B | $-416.95M | (m) | 6 month · $2.31M | 3 month · $38.05M 6 month · $70.98M | $86.45M | (m) | (m) | 609.30K |
| 2022-03-31 | (m) | $787.00K | $3.57B | (m) | $-1.30M | $-1.31M | $-3.41B | $65.32M | (m) | 3 month · $2.31M | 3 month · $32.93M | $85.90M | (m) | (m) | 599.36K |
| 2021-12-31 | $0.00 | $764.00K | $3.35B | (m) | $-1.40M | $-1.35M | $-3.62B | $-351.67M | (m) | 12 month · $7.29M | 12 month · $183.63M | $85.10M | (m) | (m) | 591.98K |
| 2021-09-30 | (m) | $760.00K | $3.31B | (m) | $900.00K | $861.00K | $-2.77B | $461.34M | (m) | 9 month · $7.29M | 3 month · $45.27M 9 month · $151.46M | $79.13M | (m) | (m) | 557.75K |
| 2021-06-30 | (m) | $747.00K | $3.24B | (m) | $4.20M | $4.17M | $-2.45B | $745.56M | (m) | 6 month · $5.14M | 3 month · $53.12M 6 month · $106.18M | $47.20M | (m) | (m) | 424.07K |
| 2021-03-31 | (m) | $745.00K | $3.18B | (m) | $-400.00K | $-357.00K | $-2.10B | $1.04B | (m) | 3 month · $7.29M | 3 month · $53.06M | $44.46M | (m) | (m) | 408.99K |
| 2020-12-31 | $0.00 | $714.00K | $2.54B | (m) | $7.00M | $7.02M | $-1.87B | $627.21M | (m) | 12 month · $11.42M | 12 month · $128.03M | $41.81M | (m) | (m) | 396.63K |
| 2020-09-30 | (m) | $633.00K | $1.85B | (m) | $5.00M | $-5.00M | $-1.70B | $106.44M | (m) | 3 month · $725.00K 9 month · $5.87M | 3 month · $65.70M 9 month · $77.60M | $41.21M | (m) | (m) | 391.40K |
| 2020-06-30 | (m) | $612.00K | $1.70B | (m) | $13.20M | $-13.20M | $-1.50B | $184.53M | (m) | 3 month · $2.65M 6 month · $5.14M | 3 month · $7.93M 6 month · $11.90M | $2.64M | (m) | (m) | 51.41K |
| 2020-03-31 | $0.00 | $539.00K | $1.45B | (m) | $14.40M | $-14.49M | $-1.46B | $-23.97M | (m) | 3 month · $2.50M | 3 month · $3.96M | $2.64M | (m) | (m) | 51.41K |
| 2019-12-31 | $0.00 | $324.00K | $1.26B | (m) | $-12.50M | $-12.51M | $-1.43B | $-186.02M | (m) | 12 month · $1.66M | 12 month · $17.05M | $2.58M | (m) | (m) | 46.94K |
| 2019-09-30 | $0.00 | $256.00K | $1.23B | (m) | $13.90M | $-13.85M | $-1.40B | $-189.84M | (m) | 3 month · $161.00K 9 month · $1.27M | 3 month · $2.62M 9 month · $12.80M | $2.58M | (m) | (m) | 46.94K |
| 2019-06-30 | $0.00 | $235.00K | $1.21B | (m) | $12.30M | $-12.29M | $-1.38B | $-185.49M | (m) | 3 month · $3.00K 6 month · $1.11M | 3 month · $4.62M 6 month · $10.18M | $2.45M | (m) | (m) | 22.89K |
| 2019-03-31 | $0.00 | $4.70M | $1.20B | (m) | $12.40M | $-12.36M | $-1.34B | $-150.58M | (m) | 3 month · $1.11M | 3 month · $5.56M | $2.45M | (m) | (m) | 455.43K |
| 2018-12-31 | $0.00 | $192.00K | $1.14B | (m) | $11.20M | $-11.19M | $-1.30B | $-167.94M | (m) | 12 month · $4.26M | 12 month · $18.31M | $2.45M | (m) | (m) | 22.89K |
| 2018-09-30 | $0.00 | $3.83M | $1.13B | (m) | $11.00M | $-11.03M | $-1.25B | $-126.68M | (m) | (m) | 3 month · $4.43M 9 month · $13.93M | $2.45M | (m) | (m) | 455.43K |
| 2018-06-30 | $0.00 | $3.82M | $1.13B | (m) | $11.20M | $-11.17M | $-1.21B | $-87.71M | (m) | (m) | 3 month · $4.25M 6 month · $9.50M | $2.45M | (m) | (m) | 455.43K |
| 2018-03-31 | $0.00 | $3.47M | $1.07B | (m) | $9.10M | $-9.07M | $-1.16B | $-99.37M | (m) | 3 month · $607.00K | 3 month · $5.25M | $2.45M | (m) | (m) | 455.43K |
| 2017-12-31 | $0.00 | $3.24M | $1.02B | (m) | $8.60M | $-8.62M | $-1.11B | $-101.73M | (m) | 12 month · $1.06M | 12 month · $18.31M | $2.45M | (m) | (m) | 455.43K |
| 2017-09-30 | $0.00 | $3.11M | $997.01M | (m) | $8.30M | $-8.30M | $-1.06B | $-74.15M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2017-06-30 | $0.00 | $2.90M | $969.00M | (m) | $9.60M | $-9.60M | $-1.02B | $-59.06M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2017-03-31 | $0.00 | $2.83M | $956.30M | (m) | $11.40M | $-11.34M | $-974.44M | $-29.10M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2016-12-31 | $0.00 | $2.72M | $936.00M | (m) | $11.80M | $-11.81M | $-930.00M | $-5.55M | (m) | (m) | 12 month · $19.16M | $2.45M | 12 month · $-38.52M | (m) | 455.43K |
| 2016-09-30 | $0.00 | $2.72M | $932.21M | (m) | $10.00M | $-9.80M | $-872.89M | $49.78M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2016-06-30 | $0.00 | $2.71M | $925.63M | (m) | $9.40M | $-9.14M | $-806.63M | $110.12M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2016-03-31 | $0.00 | $2.71M | $920.00M | (m) | $7.80M | $-7.55M | $-727.28M | $185.43M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2015-12-31 | $0.00 | $2.70M | $951.57M | (m) | $9.10M | $-9.12M | $-650.03M | $292.67M | (m) | 12 month · $11.91M | 12 month · $13.43M | $2.45M | (m) | (m) | 455.43K |
| 2015-09-30 | $0.00 | $2.70M | $947.05M | (m) | $9.10M | $-9.07M | $-571.22M | $367.02M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2015-06-30 | $0.00 | $2.69M | $934.18M | (m) | $8.70M | $-8.71M | $-538.10M | $387.60M | (m) | (m) | (m) | $2.45M | (m) | (m) | (m) |
| 2015-03-31 | $0.00 | $2.68M | $926.69M | (m) | $9.70M | $-9.76M | $-517.46M | $399.71M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2014-12-31 | $0.00 | $2.39M | $729.37M | (m) | $6.50M | $-6.61M | $-493.09M | $229.62M | (m) | 12 month · $7.11M | 12 month · $6.09M | $2.45M | (m) | (m) | 455.43K |
| 2014-09-30 | (m) | $2.39M | $727.37M | (m) | (m) | $-4.11M | $-461.55M | $261.65M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2014-06-30 | (m) | $2.39M | $724.91M | (m) | (m) | $-1.29M | $-441.82M | $281.73M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2014-03-31 | (m) | $2.10M | $615.28M | (m) | (m) | $90.00K | $-423.96M | $191.06M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2013-12-31 | $0.00 | $2.09M | $612.90M | (m) | $200.00K | $839.00K | $-410.15M | $203.23M | (m) | 12 month · $6.07M | 12 month · $2.48M | $2.45M | (m) | (m) | 455.43K |
| 2013-09-30 | (m) | $2.09M | $611.91M | (m) | (m) | $1.11M | $-396.09M | $216.57M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2013-06-30 | (m) | $1.53M | $450.30M | (m) | (m) | $637.00K | $-380.79M | $69.23M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2013-03-31 | (m) | $1.52M | $446.19M | (m) | (m) | $469.00K | $-368.16M | $77.57M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2012-12-31 | (m) | $1.48M | $438.94M | (m) | (m) | $430.00K | $-358.16M | $80.24M | (m) | 12 month · $365.00K | 12 month · $2.09M | $2.45M | (m) | (m) | 455.43K |
| 2012-09-30 | (m) | $1.36M | $411.56M | (m) | (m) | $1.04M | $-350.13M | $61.38M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2012-06-30 | (m) | $1.33M | $404.18M | (m) | (m) | $940.00K | $-342.91M | $61.08M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2012-03-31 | (m) | $1.23M | $391.56M | (m) | (m) | $976.00K | $-336.99M | $54.32M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2011-12-31 | (m) | $1.18M | $383.95M | (m) | (m) | $832.00K | $-329.66M | $53.85M | (m) | 12 month · $246.00K | 12 month · $2.05M | $2.45M | (m) | 12 month · $100.00K | 455.43K |
| 2011-09-30 | $0.00 | $1.15M | $380.93M | (m) | (m) | $913.00K | $-325.95M | $54.60M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2011-06-30 | $0.00 | $1.15M | $380.97M | (m) | (m) | $910.00K | $-322.74M | $56.27M | (m) | (m) | (m) | $2.45M | (m) | (m) | 455.43K |
| 2010-12-31 | $0.00 | $1.11M | $371.48M | (m) | (m) | $772.00K | $-310.29M | $59.05M | (m) | 12 month · $468.00K | 12 month · $1.34M | $2.45M | (m) | (m) | 455.43K |
| 2009-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $69.95M | (m) | (m) | 12 month · $1.53M | (m) | (m) | (m) | (m) |
| 2008-12-31 | (m) | (m) | (m) | (m) | (m) | (m) | (m) | $42.95M | (m) | (m) | (m) | (m) | (m) | (m) | (m) |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Vir Biotechnology, Inc. (VIR) | United States | $1.814B | -6.85 |
| Hemab Therapeutics Holdings, Inc. (COAG) | United States | $1.672B | |
| Immunocore Holdings plc (IMCR) | $1.613B | -90.43 | |
| Taysha Gene Therapies, Inc. (TSHA) | United States | $1.564B | -14.80 |
| Vericel Corp (VCEL) | United States | $2.011B | 93.97 |
| Inhibrx Biosciences, Inc. (INBX) | United States | $1.477B | -10.08 |
| Maze Therapeutics, Inc. (MAZE) | United States | $1.457B | -12.40 |
| RECURSION PHARMACEUTICALS, INC. (RXRX) | United States | $2.080B | -3.78 |
| Kodiak Sciences Inc. (KOD) | United States | $2.090B | -10.12 |
| ADMA BIOLOGICS, INC. (ADMA) | United States | $2.131B | 11.16 |